Literature DB >> 3692611

In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin.

W Heizmann1, F Heilmann, H Werner.   

Abstract

The antimicrobial susceptibility of 195 recent clinical isolates of anaerobic bacteria was studied to ampicillin alone, ampicillin + 1 mg/l sulbactam, ampicillin + 5 mg/l sulbactam, and cefoxitin by means of agar dilution tests. The ampicillin-sulbactam combinations were the most effective drugs against species of the Bacteroides fragilis group, the MIC90 of ampicillin + 5 mg/l sulbactam for B. fragilis being less than 1 mg/l, compared to 256 mg/l of ampicillin, 4 mg/l of ampicillin + 1 mg/l sulbactam, and 8 mg/l of cefoxitin. No significant difference between ampicillin alone and in combination with sulbactam was observed against gram-positive anaerobic rods, Peptococcus spp. and Peptostreptococcus spp. with MIC's less than 2 mg/l.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3692611     DOI: 10.1007/bf01647747

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  Medium for use in antibiotic susceptibility testing of anaerobic bacteria.

Authors:  T D Wilkins; S Chalgren
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

2.  Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.

Authors:  V L Sutter; A L Barry; T D Wilkins; R J Zabransky
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

Review 3.  beta-Lactamase inhibitors in perspective.

Authors:  K Bush; R B Sykes
Journal:  J Antimicrob Chemother       Date:  1983-02       Impact factor: 5.790

4.  Inhibitory activity of cefotetan and other beta-lactams against anaerobes.

Authors:  H Werner
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

5.  A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor.

Authors:  N Aswapokee; H C Neu
Journal:  J Antibiot (Tokyo)       Date:  1978-12       Impact factor: 2.649

6.  Concentrations of ampicillin plus sulbactam in serum and intestinal mucosa and effects on the colonic microflora in patients undergoing colorectal surgery.

Authors:  L Kager; A S Malmborg; S Sjöstedt; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

7.  In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.

Authors:  H M Wexler; B Harris; W T Carter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

  7 in total
  4 in total

1.  Comparison of four commercial microdilution systems for susceptibility testing of anaerobic bacteria.

Authors:  W Heizmann; H Werner; B Herb
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

2.  Infectious complications after 809 biliary tract operations and results of a prospective randomized single-blind study comparing cefoxitin versus ampicillin plus an inhibitor of beta-lactamases.

Authors:  D H Wittmann; P Koltowski; J Oleszkiewicz; A P Walker
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

Review 3.  Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys.

Authors:  L Dubreuil; M Derriennic; A Sedallian; C Romond; A L Courtieu
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

4.  Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.

Authors:  W R Heizmann; F Heilmann; B Egeler; H Werner
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.